204 related articles for article (PubMed ID: 15715476)
1. Structure-based drug discovery using GPCR homology modeling: successful virtual screening for antagonists of the alpha1A adrenergic receptor.
Evers A; Klabunde T
J Med Chem; 2005 Feb; 48(4):1088-97. PubMed ID: 15715476
[TBL] [Abstract][Full Text] [Related]
2. Protein-based virtual screening of chemical databases. II. Are homology models of G-Protein Coupled Receptors suitable targets?
Bissantz C; Bernard P; Hibert M; Rognan D
Proteins; 2003 Jan; 50(1):5-25. PubMed ID: 12471595
[TBL] [Abstract][Full Text] [Related]
3. Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols.
Evers A; Hessler G; Matter H; Klabunde T
J Med Chem; 2005 Aug; 48(17):5448-65. PubMed ID: 16107144
[TBL] [Abstract][Full Text] [Related]
4. Molecular modeling of A1 and A2A adenosine receptors: comparison of rhodopsin- and beta2-adrenergic-based homology models through the docking studies.
Yuzlenko O; Kieć-Kononowicz K
J Comput Chem; 2009 Jan; 30(1):14-32. PubMed ID: 18496794
[TBL] [Abstract][Full Text] [Related]
5. Three-dimensional models of histamine H3 receptor antagonist complexes and their pharmacophore.
Axe FU; Bembenek SD; Szalma S
J Mol Graph Model; 2006 May; 24(6):456-64. PubMed ID: 16386444
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening.
Cavasotto CN; Orry AJ; Murgolo NJ; Czarniecki MF; Kocsi SA; Hawes BE; O'Neill KA; Hine H; Burton MS; Voigt JH; Abagyan RA; Bayne ML; Monsma FJ
J Med Chem; 2008 Feb; 51(3):581-8. PubMed ID: 18198821
[TBL] [Abstract][Full Text] [Related]
7. Computational study of antagonist/alpha1A adrenoceptor complexes--observations of conformational variations on the formation of ligand/receptor complexes.
Kinsella GK; Rozas I; Watson GW
J Med Chem; 2006 Jan; 49(2):501-10. PubMed ID: 16420037
[TBL] [Abstract][Full Text] [Related]
8. Two model system of the alpha1A-adrenoceptor docked with selected ligands.
Asher WB; Hoskins SN; Slasor LA; Morris DH; Cook EM; Bautista DL
J Chem Inf Model; 2007; 47(5):1906-12. PubMed ID: 17715910
[TBL] [Abstract][Full Text] [Related]
9. PREDICT modeling and in-silico screening for G-protein coupled receptors.
Shacham S; Marantz Y; Bar-Haim S; Kalid O; Warshaviak D; Avisar N; Inbal B; Heifetz A; Fichman M; Topf M; Naor Z; Noiman S; Becker OM
Proteins; 2004 Oct; 57(1):51-86. PubMed ID: 15326594
[TBL] [Abstract][Full Text] [Related]
10. Binding site analysis of full-length alpha1a adrenergic receptor using homology modeling and molecular docking.
Pedretti A; Elena Silva M; Villa L; Vistoli G
Biochem Biophys Res Commun; 2004 Jun; 319(2):493-500. PubMed ID: 15178433
[TBL] [Abstract][Full Text] [Related]
11. Drug design strategies for targeting G-protein-coupled receptors.
Klabunde T; Hessler G
Chembiochem; 2002 Oct; 3(10):928-44. PubMed ID: 12362358
[TBL] [Abstract][Full Text] [Related]
12. Homology modeling of the serotonin 5-HT1A receptor using automated docking of bioactive compounds with defined geometry.
Nowak M; Kołaczkowski M; Pawłowski M; Bojarski AJ
J Med Chem; 2006 Jan; 49(1):205-14. PubMed ID: 16392805
[TBL] [Abstract][Full Text] [Related]
13. Homology model-based virtual screening for GPCR ligands using docking and target-biased scoring.
Radestock S; Weil T; Renner S
J Chem Inf Model; 2008 May; 48(5):1104-17. PubMed ID: 18442221
[TBL] [Abstract][Full Text] [Related]
14. Identification of nonpeptide CCR5 receptor agonists by structure-based virtual screening.
Kellenberger E; Springael JY; Parmentier M; Hachet-Haas M; Galzi JL; Rognan D
J Med Chem; 2007 Mar; 50(6):1294-303. PubMed ID: 17311371
[TBL] [Abstract][Full Text] [Related]
15. First pharmacophore model of CCR3 receptor antagonists and its homology model-assisted, stepwise virtual screening.
Jain V; Saravanan P; Arvind A; Mohan CG
Chem Biol Drug Des; 2011 May; 77(5):373-87. PubMed ID: 21284830
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional model of the human urotensin-II receptor: docking of human urotensin-II and nonpeptide antagonists in the binding site and comparison with an antagonist pharmacophore model.
Lescot E; Sopkova-de Oliveira Santos J; Colloc'h N; Rodrigo J; Milazzo-Segalas I; Bureau R; Rault S
Proteins; 2008 Oct; 73(1):173-84. PubMed ID: 18409194
[TBL] [Abstract][Full Text] [Related]
17. Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening.
Klabunde T; Giegerich C; Evers A
J Med Chem; 2009 May; 52(9):2923-32. PubMed ID: 19374402
[TBL] [Abstract][Full Text] [Related]
18. Ligand-supported homology modeling of g-protein-coupled receptor sites: models sufficient for successful virtual screening.
Evers A; Klebe G
Angew Chem Int Ed Engl; 2004 Jan; 43(2):248-51. PubMed ID: 14695622
[No Abstract] [Full Text] [Related]
19. Molecular modeling studies on the human neuropeptide S receptor and its antagonists.
Dal Ben D; Antonini I; Buccioni M; Lambertucci C; Marucci G; Vittori S; Volpini R; Cristalli G
ChemMedChem; 2010 Mar; 5(3):371-83. PubMed ID: 20087922
[TBL] [Abstract][Full Text] [Related]
20. Computational development of an alpha1A-adrenoceptor model in a membrane mimic.
Kinsella GK; Rozas I; Watson GW
Biochem Biophys Res Commun; 2004 Nov; 324(2):916-21. PubMed ID: 15474515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
